BE
Schedule 13G filing
Bass Edward P disclosed a 7.5% stake in Aquestive Therapeutics, Inc. (AQST)
Bass Edward P reported owning 7.5% of Aquestive Therapeutics, Inc. (AQST) (9,385,561 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G
More AQST insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.